Want to join the conversation?
$VRTX said it lowered Orkambi revenue guidance to range of $950-990MM from prior outlook of $1.0-1.1Bil. $VRTX expects 3Q16 Orkambi revenue of $230-235MM. The approval of Orkambi in people ages 6 through 11 will drive growth in the U.S. in 4Q16.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.